4931-70-8(n-Octyl L-2-pyrrolidone-5-carboxylate) Price
This page is the exclusive Price page for 4931-70-8(n-Octyl L-2-pyrrolidone-5-carboxylate).
This page is dedicated to presenting you with the most accurate and real-time updated Price information about this important compound,thereby providing a strong basis for you when making relevant purchasing decisions and helping you understand the market Price dynamics more comprehensively and clearly.
n-Octyl L-2-pyrrolidone-5-carboxylate Price
| Related Categories | No. | Brand | Purity | Specification | Price | Update time | Buy |
|---|---|---|---|---|---|---|---|
| Chemenu | CM397156-5g | chemenu | 95%+ | 5g | $190 | 01 Jan. 2023 | |
| A FA AI SHA ， SAI MO FEI SHI ER KE JI QI XIA GONG SI | B21838-5g | alfa | 98% | 5g | ￥1100.00 | 26 Feb. 2023 | |
| A FA AI SHA ， SAI MO FEI SHI ER KE JI QI XIA GONG SI | B21838-25g | alfa | 98% | 25g | ￥2577.00 | 26 Feb. 2023 | |
| eNovation Chemicals LLC | D765436-5g | enovation | 98% | 5g | $280 | 04 Sep. 2023 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1536314-1g | le yan | 98% | 1g | ￥285.00 | 11 May. 2024 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1536314-5g | le yan | 98% | 5g | ￥742.00 | 11 May. 2024 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1536314-25g | le yan | 98% | 25g | ￥3672.00 | 11 May. 2024 |
Recommended suppliers
Hunan Well Medicine Synthesis Technology Co., Ltd.
Audited Supplier
Gold Member
Audited Supplier
CN Supplier
Reagent
Company nature: Private enterprises
鉅瀾化工科技(青島)有限公司
Audited Supplier
Gold Member
Audited Supplier
CN Supplier
Bulk
Company nature: Private enterprises
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Audited Supplier
Gold Member
Audited Supplier
CN Supplier
Bulk
Company nature: Private enterprises
Shanghai Hongxiang Biomedical Technology Co., Ltd.
Audited Supplier
Gold Member
Audited Supplier
CN Supplier
Bulk
Company nature: Private enterprises
TAIXING JOXIN BIO-TEC CO.,LTD.
Audited Supplier
Gold Member
Audited Supplier
CN Supplier
Bulk
Company nature: Private enterprises